Clinical Trial Update: A Study Evaluating the Safety, Tolerability, and Effect on Microvascular Obstruction of Intravenous Temanogrel in Adult Participants Undergoing Percutaneous Coronary Intervention [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating safety and tolerability of intravenous Temanogrel in adults undergoing PCI for microvascular obstruction was terminated with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Microvascular Obstruction

Drugs mentioned

• Temanogrel (Temanogrel)

Snippet

Sponsor: Pfizer | Conditions: Microvascular Obstruction | Phase 2 | Status: TERMINATED | Results posted: 2023-12-12